404 related articles for article (PubMed ID: 28202602)
1. Cancer cell behaviors mediated by dysregulated pH dynamics at a glance.
White KA; Grillo-Hill BK; Barber DL
J Cell Sci; 2017 Feb; 130(4):663-669. PubMed ID: 28202602
[TBL] [Abstract][Full Text] [Related]
2. The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela.
Cardone RA; Alfarouk KO; Elliott RL; Alqahtani SS; Ahmed SBM; Aljarbou AN; Greco MR; Cannone S; Reshkin SJ
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357694
[TBL] [Abstract][Full Text] [Related]
3. The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer.
Alfarouk KO; Ahmed SBM; Ahmed A; Elliott RL; Ibrahim ME; Ali HS; Wales CC; Nourwali I; Aljarbou AN; Bashir AHH; Alhoufie STS; Alqahtani SS; Cardone RA; Fais S; Harguindey S; Reshkin SJ
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272658
[TBL] [Abstract][Full Text] [Related]
4. Cancer and pH Dynamics: Transcriptional Regulation, Proteostasis, and the Need for New Molecular Tools.
Czowski BJ; Romero-Moreno R; Trull KJ; White KA
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992762
[TBL] [Abstract][Full Text] [Related]
5. Na+-H+ exchanger, pH regulation and cancer.
Reshkin SJ; Cardone RA; Harguindey S
Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):85-99. PubMed ID: 22738122
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated pH: a perfect storm for cancer progression.
Webb BA; Chimenti M; Jacobson MP; Barber DL
Nat Rev Cancer; 2011 Aug; 11(9):671-7. PubMed ID: 21833026
[TBL] [Abstract][Full Text] [Related]
7. pH gradient reversal fuels cancer progression.
Zheng T; Jäättelä M; Liu B
Int J Biochem Cell Biol; 2020 Aug; 125():105796. PubMed ID: 32593663
[TBL] [Abstract][Full Text] [Related]
8. The Interplay between Dysregulated Ion Transport and Mitochondrial Architecture as a Dangerous Liaison in Cancer.
Pedersen SF; Flinck M; Pardo LA
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069047
[TBL] [Abstract][Full Text] [Related]
9. The role of low intracellular or extracellular pH in sensitization to hyperthermia.
Chu GL; Dewey WC
Radiat Res; 1988 Apr; 114(1):154-67. PubMed ID: 3353502
[TBL] [Abstract][Full Text] [Related]
10. Systems analysis of intracellular pH vulnerabilities for cancer therapy.
Persi E; Duran-Frigola M; Damaghi M; Roush WR; Aloy P; Cleveland JL; Gillies RJ; Ruppin E
Nat Commun; 2018 Jul; 9(1):2997. PubMed ID: 30065243
[TBL] [Abstract][Full Text] [Related]
11. pH sensing in skin tumors: Methods to study the involvement of GPCRs, acid-sensing ion channels and transient receptor potential vanilloid channels.
Stolwijk JA; Sauer L; Ackermann K; Nassios A; Aung T; Haerteis S; Bäumner AJ; Wegener J; Schreml S
Exp Dermatol; 2020 Nov; 29(11):1055-1061. PubMed ID: 32658355
[TBL] [Abstract][Full Text] [Related]
12. Anillin is an emerging regulator of tumorigenesis, acting as a cortical cytoskeletal scaffold and a nuclear modulator of cancer cell differentiation.
Naydenov NG; Koblinski JE; Ivanov AI
Cell Mol Life Sci; 2021 Jan; 78(2):621-633. PubMed ID: 32880660
[TBL] [Abstract][Full Text] [Related]
13. Acid pH in tumors and its potential for therapeutic exploitation.
Tannock IF; Rotin D
Cancer Res; 1989 Aug; 49(16):4373-84. PubMed ID: 2545340
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase M2 at a glance.
Yang W; Lu Z
J Cell Sci; 2015 May; 128(9):1655-60. PubMed ID: 25770102
[TBL] [Abstract][Full Text] [Related]
15. Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange.
Stock C; Gassner B; Hauck CR; Arnold H; Mally S; Eble JA; Dieterich P; Schwab A
J Physiol; 2005 Aug; 567(Pt 1):225-38. PubMed ID: 15946960
[TBL] [Abstract][Full Text] [Related]
16. Acid-Induced Downregulation of ASS1 Contributes to the Maintenance of Intracellular pH in Cancer.
Silberman A; Goldman O; Boukobza Assayag O; Jacob A; Rabinovich S; Adler L; Lee JS; Keshet R; Sarver A; Frug J; Stettner N; Galai S; Persi E; Halpern KB; Zaltsman-Amir Y; Pode-Shakked B; Eilam R; Anikster Y; Nagamani SCS; Ulitsky I; Ruppin E; Erez A
Cancer Res; 2019 Feb; 79(3):518-533. PubMed ID: 30573518
[TBL] [Abstract][Full Text] [Related]
17. Targeting pH regulating proteins for cancer therapy-Progress and limitations.
Parks SK; Pouysségur J
Semin Cancer Biol; 2017 Apr; 43():66-73. PubMed ID: 28137473
[TBL] [Abstract][Full Text] [Related]
18. pH Gradient Reversal: An Emerging Hallmark of Cancers.
Sharma M; Astekar M; Soi S; Manjunatha BS; Shetty DC; Radhakrishnan R
Recent Pat Anticancer Drug Discov; 2015; 10(3):244-58. PubMed ID: 26152150
[TBL] [Abstract][Full Text] [Related]
19. Mechanotransduction at focal adhesions: from physiology to cancer development.
Seong J; Wang N; Wang Y
J Cell Mol Med; 2013 May; 17(5):597-604. PubMed ID: 23601032
[TBL] [Abstract][Full Text] [Related]
20. BAX inhibitor-1 enhances cancer metastasis by altering glucose metabolism and activating the sodium-hydrogen exchanger: the alteration of mitochondrial function.
Lee GH; Yan C; Shin SJ; Hong SC; Ahn T; Moon A; Park SJ; Lee YC; Yoo WH; Kim HT; Kim DS; Chae SW; Kim HR; Chae HJ
Oncogene; 2010 Apr; 29(14):2130-41. PubMed ID: 20118983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
